Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis

BACKGROUND: The optimal antithrombotic therapy in patients with ST‐segment‐elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI) remains a matter of debate. This updated meta‐analysis investigated the impact of (1) bivalirudin (with and without prolonged infusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahrni, Gregor, Wolfrum, Mathias, De Maria, Giovanni Luigi, Banning, Adrian P., Benedetto, Umberto, Kharbanda, Rajesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015387/
https://www.ncbi.nlm.nih.gov/pubmed/27451466
http://dx.doi.org/10.1161/JAHA.116.003515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015387/
https://www.ncbi.nlm.nih.gov/pubmed/27451466
http://dx.doi.org/10.1161/JAHA.116.003515

Ejemplares similares